Readystate Asset Management LP Arcellx, Inc. Put Options Transaction History
Readystate Asset Management LP
- $3.27 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ACLX
# of Institutions
211Shares Held
48.5MCall Options Held
764KPut Options Held
296K-
Paradigm Biocapital Advisors LP New York, NY4.49MShares$317 Million15.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.99MShares$281 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$264 Million23.3% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$248 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.04MShares$214 Million4.14% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.09B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...